BeOne Medicines AG (ONC)

Revenue

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013
BRUKINSA Revenue	4.23B	3.93B	2.64B
BRUKINSA Revenue Growth	7.72%	48.57%	104.92%
TEVIMBRA Revenue	772.38M	737.30M	620.84M
TEVIMBRA Revenue Growth	4.76%	18.76%	15.69%
XGEVA Revenue	325.48M	305.98M	224.40M
XGEVA Revenue Growth	6.37%	36.35%	141.74%
BLINCYTO Revenue	114.35M	104.22M	74.33M
BLINCYTO Revenue Growth	9.72%	40.22%	36.78%
KYPROLIS Revenue	72.22M	74.97M	66.17M
KYPROLIS Revenue Growth	-3.68%	13.30%	66.26%
POBEVCY Revenue	45.78M	47.40M	53.51M
POBEVCY Revenue Growth	-3.41%	-11.42%	-5.37%
REVLIMID Revenue	-	-	36.03M
REVLIMID Revenue Growth	-	-	-52.61%
Other Product Revenue	-	-	60.04M
Other Product Revenue Growth	-	-	38.66%
Total Other Product Revenue	98.98M	83.69M	96.07M
Total Other Product Revenue Growth	18.27%	-12.88%	-19.48%
Total Product Revenue	5.66B	5.28B	3.78B
Total Product Revenue Growth	7.17%	39.75%	72.59%
Collaboration Revenue	78.33M	60.97M	30.70M
Collaboration Revenue Growth	28.47%	98.64%	-88.59%
Revenue (Total)	5.67B	5.34B	3.81B
Revenue (Total) Growth	6.20%	40.23%	54.96%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013
U.S. Revenue	3.10B	2.88B	1.96B
U.S. Revenue Growth	7.47%	47.14%	73.50%
China Revenue	1.75B	1.68B	1.41B
China Revenue Growth	4.31%	19.00%	28.07%
Europe Revenue	686.81M	611.37M	362.63M
Europe Revenue Growth	12.34%	68.59%	79.51%
Rest of World Revenue	205.10M	171.81M	78.81M
Rest of World Revenue Growth	19.38%	118.00%	196.33%
Rest of World Revenue (Pre-Q3 2022 Reporting)	891.91M	783.18M	441.44M
Rest of World Revenue (Pre-Q3 2022 Reporting) Growth	13.88%	77.42%	93.10%
Revenue (Other)	-65.11M	2.00K	-6.00K
Revenue (Total)	5.67B	5.34B	3.81B
Revenue (Total) Growth	6.20%	40.23%	54.96%

Data Source: Fiscal.ai Last updated: May 6, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 17, 2026

Data Sources Report a data error